GRACEcast
Expert oncologists provide brief, distilled summaries of the most central issues in cancer management and emerging approaches for patients and caregivers. The Global Resource for Advancing Cancer Education (GRACE) is committed to providing the knowledge that will help enable the general public to be informed participants in their own care. Visit cancerGRACE.org for more info.

Dr. Jack West reviews the encouraging results with selumetinib, a MEK inhibitor, in combination with chemotherapy for patients with advanced NSCLC and a KRAS mutation, the most common molecular marker seen in lung cancer. 

Direct download: GRACEcastUC-017_Lung-Video_New_Option_for_Common_LC_Mutation.m4v
Category:Lung-Cancer-Video -- posted at: 2:12pm PST

Dr. Ramalingam, from Winship Cancer Center at Emory University in Atlanta, dispels several myths that have created barriers to patient participation in clinical trials and highlights the rights of a patient interested in enrolling on a study.


Dr. Ramalingam, from Winship Cancer Center at Emory University in Atlanta, dispels several myths that have created barriers to patient participation in clinical trials and highlights the rights of a patient interested in enrolling on a study.


Dr. Ramalingam, from Winship Cancer Center at Emory University in Atlanta, explains the process of developing a clinical trial, from identifying the most important questions to navigating it through the design and implementation process and enrolling patients.

Direct download: GRACEcast-135_CA-101-Video_How_Are_Clinical_Trials_Developed.m4v
Category:Cancer-101-Video -- posted at: 4:54pm PST

Dr. Ramalingam, from Winship Cancer Center at Emory University in Atlanta, explains the process of developing a clinical trial, from identifying the most important questions to navigating it through the design and implementation process and enrolling patients.

Direct download: GRACEcast-135_CA-101-Audio_How_Are_Clinical_Trials_Developed.mp3
Category:Cancer-101-Audio -- posted at: 4:53pm PST

Dr. Jack West offers thoughts on the disappointing negative results of the START trial with the immunotherapy Stimuvax, and what this might mean as we anticipate the results of future trials of other immunotherapies moving forward in clinical trials in lung cancer.

Direct download: GRACEcastUC-016_Lung-Video_High_Profile_Failure_for_Stimuvax.m4v
Category:Lung-Cancer-Video -- posted at: 4:52pm PST

Dr. Jack West discusses the likely biological underpinnings of a mixed response to treatment for advanced lung cancer and the potential utility of multiple biopsies to learn more about biological changes over time and in different tumor areas.

Direct download: GRACEcastUC-015_Lung-Video_Biology_of_Mixed_Response_in_LC.m4v
Category:Lung-Cancer-Video -- posted at: 8:00am PST

Dr. Ramalingam, from Winship Cancer Center at Emory University in Atlanta, reviews what constitutes a clinical trial and discusses the phases of studies in the process of clinical research.

Direct download: GRACEcast-134_CA-101-Video_Ramalingam_on_Clinical_Trials.m4v
Category:Cancer-101-Video -- posted at: 6:56pm PST

Dr. Ramalingam, from Winship Cancer Center at Emory University in Atlanta, reviews what constitutes a clinical trial and discusses the phases of studies in the process of clinical research.

Direct download: GRACEcast-134_CA-101-Audio_Ramalingam_on_Clinical_Trials.mp3
Category:Cancer-101-Audio -- posted at: 6:55pm PST

Dr. Jack West thanks the GRACE community for their generous support in our recent Annual Appeal and offers his wishes for a happy and healthy 2013.

Direct download: GRACEcastUC-014_CA-101-Video_Happy_New_Year_from_GRACE.m4v
Category:Cancer-101-Video -- posted at: 9:55am PST